{"count":2,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/1e4af304-f86a-4731-8dcb-f0f00d17cb82/","filing_uuid":"1e4af304-f86a-4731-8dcb-f0f00d17cb82","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1e4af304-f86a-4731-8dcb-f0f00d17cb82/print/","filing_document_content_type":"text/html","income":null,"expenses":"60000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Rachel N. Meyer","dt_posted":"2026-07-16T12:56:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 H Street, N.W.","registrant_address_2":"Suite 900","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":80656,"url":"https://lda.gov/api/v1/registrants/80656/","house_registrant_id":36285,"name":"AMERICAN SOCIETY OF NEPHROLOGY","description":"Professional Medical Society - professional education","address_1":"1401 H Street, N.W.","address_2":"Suite 900","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RACHEL N. MEYER","contact_telephone":"+1 505-720-2009","dt_updated":"2026-07-16T12:59:08.586527-04:00"},"client":{"id":170996,"url":"https://lda.gov/api/v1/clients/170996/","client_id":12,"name":"AMERICAN SOCIETY OF NEPHROLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67147,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55611,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"NELL","last_name":"MEYER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145666,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"AHEARN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for significant revision or recision of the proposed Regulation for Federal Financial Assistance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67147,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":"Senior Manager of Policy and Government Affairs","new":false},{"lobbyist":{"id":55611,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"NELL","last_name":"MEYER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/17d002ae-40ce-4332-aa2b-ac1773237fe0/","filing_uuid":"17d002ae-40ce-4332-aa2b-ac1773237fe0","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/17d002ae-40ce-4332-aa2b-ac1773237fe0/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Patrick Meade","dt_posted":"2026-10-20T15:32:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2011 Crystal Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22202","registrant":{"id":401104679,"url":"https://lda.gov/api/v1/registrants/401104679/","house_registrant_id":null,"name":"CURA STRATEGIES","description":"Public relations/advocacy firm","address_1":"2011 Crystal Drive","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22202","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SCOTT LEEZER","contact_telephone":"+1 202-827-6045","dt_updated":"2026-08-04T16:10:40.303522-04:00"},"client":{"id":206421,"url":"https://lda.gov/api/v1/clients/206421/","client_id":75,"name":"PKD FOUNDATION","general_description":"non-profit organization that funds and advocates for polycystic kidney disease research","client_government_entity":false,"client_self_select":null,"state":"MO","state_display":"Missouri","country":"US","country_display":"United States of America","ppb_state":"MO","ppb_state_display":"Missouri","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-18"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Federal funding for PKD research at the National Institutes of Health (NIH).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67861,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":"C","last_name":"LEEZER","suffix":null,"suffix_display":null},"covered_position":"Aide to Senator Dick Durbin (D-IL)","new":false},{"lobbyist":{"id":111814,"prefix":null,"prefix_display":null,"first_name":"PATRICK","nickname":null,"middle_name":null,"last_name":"MEADE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155651,"prefix":null,"prefix_display":null,"first_name":"MADELYN","nickname":null,"middle_name":null,"last_name":"HELMUS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67861,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":"C","last_name":"LEEZER","suffix":null,"suffix_display":null},"covered_position":"Aide to Senator Dick Durbin (D-IL)","new":false},{"lobbyist":{"id":111814,"prefix":null,"prefix_display":null,"first_name":"PATRICK","nickname":null,"middle_name":null,"last_name":"MEADE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155651,"prefix":null,"prefix_display":null,"first_name":"MADELYN","nickname":null,"middle_name":null,"last_name":"HELMUS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Inclusion of PKD as a covered topic area under the Department of Defense's Peer Reviewed Medical Research Program (PRMRP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67861,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":"C","last_name":"LEEZER","suffix":null,"suffix_display":null},"covered_position":"Aide to Senator Dick Durbin (D-IL)","new":false},{"lobbyist":{"id":111814,"prefix":null,"prefix_display":null,"first_name":"PATRICK","nickname":null,"middle_name":null,"last_name":"MEADE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155651,"prefix":null,"prefix_display":null,"first_name":"MADELYN","nickname":null,"middle_name":null,"last_name":"HELMUS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}